Literature DB >> 2558015

Biochemical characterization of phospholipase D activity from human neutrophils.

J Balsinde1, E Diez, B Fernandez, F Mollinedo.   

Abstract

We have found a phospholipase D activity in the postnuclear fraction of human neutrophils, employing phosphatidylinositol as exogenous substrate. This phospholipase D activity was assessed by both phosphatidate formation and by free inositol release in the presence of 15 mM LiCl in the reaction mixture and in the absence of Mg2+ ions to prevent inositol-1-phosphate phosphatase activity. To assess further the phospholipase D activity, we studied its capacity to catalyze a transphosphatidylation reaction, as a unique feature of the enzyme. It was detected as [14C]phosphatidylethanol formation when the postnuclear fraction was incubated with [14C]phosphatidylinositol in the presence of ethanol. The phospholipase D showed a major optimum pH at 7.5 and a minor one at pH 5.0. Neutral and acid phospholipase D activities were differentially located in subcellular fractionation studies of resting neutrophils, namely in the cytosol and in the azurophilic granules, respectively. Neutral phospholipase D required Ca2+ ions to the active, whereas the acid enzyme activity was Ca2(+)-independent. The neutral phospholipase D activity showed a certain specificity for phosphatidylinositol, as it was able to hydrolyze phosphatidylinositol at a much higher rate than phosphatidylcholine, in the absence and in the presence of different detergents. This neutral phospholipase D activity behaved as a protein of high molecular mass (350-400 kDa) by gel filtration chromatography. Moreover, neutral phospholipase D activity was detected in the postnuclear fraction of human monocytes, by measuring free inositol release from phosphatidylinositol as exogenous substrate, under the same experimental conditions as those used with neutrophils. The enzyme displayed similar specific activities in both cell types as well as the same degree of activation after cell stimulation with the calcium ionophore A23187. These results demonstrate the existence of two phospholipase D activities with different pH optima and intracellular location in human neutrophils. Furthermore, these results suggest that this phospholipase D can play a role in signal-transducing processes during cell stimulation in human phagocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558015     DOI: 10.1111/j.1432-1033.1989.tb15265.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

Review 1.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Phospholipase D1b and D2a generate structurally identical phosphatidic acid species in mammalian cells.

Authors:  T R Pettitt; M McDermott; K M Saqib; N Shimwell; M J Wakelam
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

3.  Guanine-nucleotide- and adenine-nucleotide-dependent regulation of phospholipase D in electropermeabilized HL-60 granulocytes.

Authors:  M S Xie; G R Dubyak
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

4.  Phospholipase D activation in human natural killer cells through the Kp43 and CD16 surface antigens takes place by different mechanisms. Involvement of the phospholipase D pathway in tumor necrosis factor alpha synthesis.

Authors:  M A Balboa; J Balsinde; J Aramburu; F Mollinedo; M López-Botet
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

5.  ITPK1 mediates the lipid-independent synthesis of inositol phosphates controlled by metabolism.

Authors:  Yann Desfougères; Miranda S C Wilson; Debabrata Laha; Gregory J Miller; Adolfo Saiardi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

Review 6.  Lipid Droplets, Phospholipase A2, Arachidonic Acid, and Atherosclerosis.

Authors:  Miguel A Bermúdez; María A Balboa; Jesús Balsinde
Journal:  Biomedicines       Date:  2021-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.